Oxana Beskrovnaya is Chief Scientific Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 195,840 shares of DYN, which is worth approximately $1.8 Million. The most recent transaction as insider was on Dec 12, 2022, when has been sold 680 shares (Common Stock) at a price of $10.87 per share, resulting in proceeds of $7,391. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 196K
0% 3M change
32.76% 12M change
Total Value Held $1.8 Million

Oxana Beskrovnaya Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2022
SELL
Open market or private sale
$7,391 $10.87 p/Share
680 Reduced 0.75%
90,145 Common Stock
Dec 09 2022
BUY
Grant, award, or other acquisition
-
40,000 Added 30.58%
90,825 Common Stock
Sep 20 2022
SELL
Sale (or disposition) back to the issuer
$19,358 $13.7 p/Share
1,413 Reduced 2.7%
50,825 Common Stock
Sep 15 2022
SELL
Sale (or disposition) back to the issuer
$10,004 $14.05 p/Share
712 Reduced 1.34%
52,238 Common Stock
Jun 14 2022
SELL
Sale (or disposition) back to the issuer
$3,594 $4.95 p/Share
726 Reduced 1.35%
52,950 Common Stock
Mar 11 2022
SELL
Open market or private sale
$6,050 $8.73 p/Share
693 Reduced 1.27%
53,676 Common Stock
Dec 10 2021
BUY
Grant, award, or other acquisition
-
36,524 Added 40.18%
54,369 Common Stock
Sep 21 2021
SELL
Open market or private sale
$13,323 $16.11 p/Share
827 Reduced 4.43%
17,845 Common Stock
Sep 20 2021
SELL
Open market or private sale
$9,631 $15.61 p/Share
617 Reduced 3.2%
18,672 Common Stock
OB

Oxana Beskrovnaya

Chief Scientific Officer
Waltham, MA

Track Institutional and Insider Activities on DYN

Follow Dyne Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

News

Receive news related to Dyne Therapeutics, Inc.

Track Activities on DYN